Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)-Reference-Cited by-同舟云学术

Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)

Published:2013-05 Issue:3 Volume:27 Page:155-164
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Feyler Sylvia,Selby Peter J.,Cook Gordon

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference185 articles.

1. CC chemokine receptor 7 and 9 double-deficient hematopoietic progenitors are severely impaired in seeding the adult thymus;Krueger;Blood,2010

2. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3–CD4–CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression;Godfrey;J Immunol,1993

3. Decision checkpoints in the thymus;Carpenter;Nat Immunol,2010

4. Notch signaling controls the generation and differentiation of early T lineage progenitors;Sambandam;Nat Immunol,2005

5. The earliest thymic progenitors for T cells possess myeloid lineage potential;Bell;Nature,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy;Journal for ImmunoTherapy of Cancer;2022-04

2. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy;World Journal of Clinical Cases;2021-07-26

3. Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients;Frontiers in Immunology;2021-07-05

4. Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review;Cancers;2021-05-31

5. Applications of Cutting-Edge Immunoproteomics Technology in Human Immunotherapy;Advanced Concepts in Human Immunology: Prospects for Disease Control;2020